Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1280776 · IMUX

Immunic, Inc.

Filing with the SEC SEC-reporting company New York Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Jan 6, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Several leadership changes5 reports of director or officer changes (Item 5.02) in the last 180 days.
  • Stockholders’ deficitAt the end of 2025 total liabilities exceeded total assets: stockholders’ equity was −$6.7M (XBRL data filed with the SEC).
  • Net loss in 2025Net loss of $97.2M for the year (2024: −$101M).
  • Private capital raiseOn Mar 4, 2026 the company filed Form D. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$97.2M−$101M
Total assets$24.1M$40.9M
Total liabilities$30.7M$22.4M
Stockholders’ equity−$6.7M$18.4M
Cash and equivalents$15.5M$35.7M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
IMMUNIC, INC.
Formerly: Vital Therapies Inc
CIK
0001280776
Tickers
IMUX
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
New York (outside the US)
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 13, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Sep 11, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 11, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 2.02, 5.02, 7.01, 9.01 · filed Aug 11, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 5.02, 7.01, 9.01 · filed Aug 11, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 6, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Jun 29, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed May 27, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed May 19, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 13, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 13, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Apr 28, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Apr 10, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Mar 31, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Mar 4, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 26, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Feb 26, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Feb 20, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.02, 5.02, 8.01, 9.01 · filed Feb 13, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jan 6, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jan 5, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01, 9.01 · filed Aug 7, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 7, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 11, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jun 27, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Jun 4, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 15, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 31, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Dec 18, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01, 9.01 · filed Nov 7, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 7, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01, 9.01 · filed Aug 8, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 8, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jul 24, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jul 9, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01, 9.01 · filed May 8, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 8, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01, 9.01 · filed Feb 22, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Feb 22, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jan 19, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Dec 21, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01, 9.01 · filed Nov 14, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 14, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01, 9.01 · filed Aug 3, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 3, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 11, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01, 9.01 · filed May 11, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Apr 27, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01, 9.01 · filed Feb 23, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Feb 23, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jan 20, 2023 · filing